Innovación en el tratamiento de los Sarcomas de Partes Blandas - page 5

Doxorrubicina

1971

•

FDA Appoval for STS

and bone sarcoma.

•

No specification of

prior therapy.

•

Approval based on

response

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1,2,3,4 6,7,8,9,10,11,12,13,14,15,...36